{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:51:46Z","timestamp":1767383506763,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T00:00:00Z","timestamp":1681084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Penn Center for AIDS Research","award":["10069025"],"award-info":[{"award-number":["10069025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10461-023-04060-w","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T08:03:03Z","timestamp":1681113783000},"page":"3460-3467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Acceptability and Feasibility of a Mobile Phone Application to Support HIV Pre-exposure Prophylaxis Among Women with Opioid Use Disorder"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7920-7191","authenticated-orcid":false,"given":"Aaron","family":"Richterman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Teitelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trisha","family":"Acri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"North","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasandra","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vuthy","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia E.","family":"Van Pelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Momplaisir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,10]]},"reference":[{"key":"4060_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.drugalcdep.2017.12.039","volume":"185","author":"DC Des Jarlais","year":"2018","unstructured":"Des Jarlais DC, McKnight C, Feelemyer J, et al. Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001\u20132005 and 2011\u20132015. Drug Alcohol Depend. 2018;185:391\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"4060_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.15585\/mmwr.mm6701a5","volume":"67","author":"JC Burnett","year":"2018","unstructured":"Burnett JC, Broz D, Spiller MW, Wejnert C, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs\u201420 cities, United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67(1):23\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"4060_CR3","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1016\/S2352-3018(20)30082-5","volume":"7","author":"DC Des Jarlais","year":"2020","unstructured":"Des Jarlais DC, Sypsa V, Feelemyer J, et al. HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Lancet HIV. 2020;7(6):e434-42.","journal-title":"Lancet HIV"},{"key":"4060_CR4","volume-title":"Surveillance report, 2020","author":"Philadelphia Department of Public Health AIDS Activities Coordinating Office","year":"2021","unstructured":"Philadelphia Department of Public Health AIDS Activities Coordinating Office. Surveillance report, 2020. Philadelphia: City of Philadelphia; 2021."},{"key":"4060_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugpo.2019.10.004","volume":"74","author":"BH Lambdin","year":"2019","unstructured":"Lambdin BH, Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019;74:299\u2013304.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"4060_CR6","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1007\/s10461-016-1332-y","volume":"20","author":"G Paz-Bailey","year":"2016","unstructured":"Paz-Bailey G, Noble M, Salo K, Tregear SJ. Prevalence of HIV among U.S. female sex workers: systematic review and meta-analysis. AIDS Behav. 2016;20(10):2318\u201331.","journal-title":"AIDS Behav"},{"key":"4060_CR7","unstructured":"Joint United Nations Programme on HIV\/AIDS. and STRIVE. Transactional sex and HIV risk: from analysis to action. Geneva;\u00a02018."},{"issue":"3","key":"4060_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10461-019-02612-7","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, White RH, O\u2019Rourke A, et al. Correlates of transactional sex among a Rural Population of People who inject drugs. AIDS Behav. 2020;24(3):775\u201381.","journal-title":"AIDS Behav"},{"issue":"1","key":"4060_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, et al. Opioid use fueling HIV Transmission in an urban setting: an outbreak of HIV infection among people who inject Drugs-Massachusetts, 2015\u20132018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"issue":"9883","key":"4060_CR10","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381(9883):2083\u201390.","journal-title":"Lancet"},{"issue":"5","key":"4060_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"4060_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334.","journal-title":"N Engl J Med"},{"issue":"5","key":"4060_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","volume":"19","author":"DJ Escudero","year":"2015","unstructured":"Escudero DJ, Kerr T, Wood E, et al. Acceptability of HIV Pre-exposure Prophylaxis (PREP) among people who inject drugs (PWID) in a canadian setting. AIDS Behav. 2015;19(5):752\u20137.","journal-title":"AIDS Behav"},{"issue":"6","key":"4060_CR14","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s10461-019-02767-3","volume":"24","author":"ST Allen","year":"2020","unstructured":"Allen ST, O\u2019Rourke A, White RH, et al. Barriers and facilitators to PrEP Use among People who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942\u201350.","journal-title":"AIDS Behav"},{"key":"4060_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drugalcdep.2018.08.014","volume":"195","author":"SG Sherman","year":"2019","unstructured":"Sherman SG, Schneider KE, Park JN, et al. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland. Drug Alcohol Depend. 2019;195:148\u201355.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"4060_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","volume":"14","author":"SM Walters","year":"2017","unstructured":"Walters SM, Reilly KH, Neaigus A, Braunstein S. Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention. Harm Reduct J. 2017;14(1):40.","journal-title":"Harm Reduct J"},{"key":"4060_CR17","doi-asserted-by":"publisher","first-page":"S383","DOI":"10.1097\/QAI.0000000000001415","volume":"75","author":"SM Walters","year":"2017","unstructured":"Walters SM, Rivera AV, Starbuck L. Differences in awareness of pre-exposure prophylaxis and post-exposure prophylaxis among groups at-risk for: New York City and Long Island, NY, 2011\u20132013. J Acquir Immune Defic Syndr (1999). 2017;75:S383\u201391.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"key":"4060_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","volume":"164","author":"I Kuo","year":"2016","unstructured":"Kuo I, Olsen H, Patrick R, et al. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug Alcohol Depend. 2016;164:8\u201313.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"4060_CR19","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","volume":"18","author":"M Stein","year":"2014","unstructured":"Stein M, Thurmond P, Bailey G. Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav. 2014;18(9):1694\u2013700.","journal-title":"AIDS Behav"},{"issue":"12","key":"4060_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","volume":"32","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Biancarelli DL, Childs E, et al. Limited knowledge and mixed interest in pre-exposure prophylaxis for HIV prevention among people who inject drugs. AIDS Patient Care STDS. 2018;32(12):529\u201337.","journal-title":"AIDS Patient Care STDS"},{"issue":"5","key":"4060_CR21","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490\u2013506.","journal-title":"AIDS Behav"},{"key":"4060_CR22","doi-asserted-by":"publisher","first-page":"113809","DOI":"10.1016\/j.socscimed.2021.113809","volume":"275","author":"M Felsher","year":"2021","unstructured":"Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. PrEP just isn\u2019t my priority\u201d: adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Soc Sci Med. 2021;275:113809.","journal-title":"Soc Sci Med"},{"issue":"6","key":"4060_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11904-020-00528-9","volume":"17","author":"AJ Siegler","year":"2020","unstructured":"Siegler AJ, Steehler K, Sales JM, Krakower DS. A review of HIV pre-exposure prophylaxis streamlining strategies. Curr HIV\/AIDS Rep. 2020;17(6):643\u201353.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"3","key":"4060_CR24","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","volume":"86","author":"AM Roth","year":"2021","unstructured":"Roth AM, Tran NK, Felsher M, et al. Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the project SHE demonstration study. J Acquir Immune Defic Syndr. 2021;86(3):e61\u201370.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"4060_CR25","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s10461-011-0026-8","volume":"15","author":"S Parashar","year":"2011","unstructured":"Parashar S, Palmer AK, O\u2019Brien N, et al. Sticking to it: the Effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed. AIDS Behav. 2011;15(8):1612\u201322.","journal-title":"AIDS Behav"},{"issue":"5","key":"4060_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s10461-018-2226-y","volume":"23","author":"B Barker","year":"2019","unstructured":"Barker B, Adams E, Wood E, et al. Engagement in maximally-assisted therapy and adherence to antiretroviral therapy among a cohort of Indigenous People who Use Illicit Drugs. AIDS Behav. 2019;23(5):1258\u201366.","journal-title":"AIDS Behav"},{"issue":"6","key":"4060_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1037\/a0037496","volume":"82","author":"DR Christensen","year":"2014","unstructured":"Christensen DR, Landes RD, Jackson L, et al. Adding an internet-delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014;82(6):964\u201372.","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"4060_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/03007995.2020.1846022","volume":"37","author":"YA Maricich","year":"2021","unstructured":"Maricich YA, Bickel WK, Marsch LA, Gatchalian K, Botbyl J, Luderer HF. Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder. Curr Med Res Opin. 2021;37(2):167\u201373.","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"4060_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"1","key":"4060_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.","journal-title":"Implement Sci"},{"key":"4060_CR31","doi-asserted-by":"publisher","first-page":"205031211882292","DOI":"10.1177\/2050312118822927","volume":"7","author":"Y Chun Tie","year":"2019","unstructured":"Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med. 2019;7:2050312118822927.","journal-title":"SAGE Open Med"},{"issue":"2","key":"4060_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/03007995.2020.1846023","volume":"37","author":"YA Maricich","year":"2021","unstructured":"Maricich YA, Xiong X, Gerwien R, et al. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder. Curr Med Res Opin. 2021;37(2):175\u201383.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"4060_CR33","doi-asserted-by":"publisher","first-page":"e33073","DOI":"10.2196\/33073","volume":"6","author":"S Kawasaki","year":"2022","unstructured":"Kawasaki S, Mills-Huffnagle S, Aydinoglo N, Maxin H, Nunes E. Patient- and provider-reported experiences of a Mobile Novel Digital Therapeutic in People with Opioid Use Disorder (reSET-O): feasibility and acceptability study. JMIR Form Res. 2022;6(3):e33073.","journal-title":"JMIR Form Res"},{"issue":"5","key":"4060_CR34","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/13691058.2021.1877824","volume":"24","author":"GY Jackson","year":"2022","unstructured":"Jackson GY, Darlington CK, Van Tieu H, et al. Women\u2019s views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention. Cult Health Sex. 2022;24(5):642\u201356.","journal-title":"Cult Health Sex"},{"key":"4060_CR35","doi-asserted-by":"publisher","first-page":"108167","DOI":"10.1016\/j.drugalcdep.2020.108167","volume":"214","author":"K Biello","year":"2020","unstructured":"Biello K, Salhaney P, Valente PK, et al. Ecological momentary assessment of daily drug use and harm reduction service utilization among people who inject drugs in non-urban areas: a concurrent mixed-method feasibility study. Drug Alcohol Depend. 2020;214:108167.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"4060_CR36","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/08897077.2016.1176980","volume":"37","author":"KM Collins","year":"2016","unstructured":"Collins KM, Armenta RF, Cuevas-Mota J, Liu L, Strathdee SA, Garfein RS. Factors associated with patterns of mobile technology use among persons who inject drugs. Subst Abus. 2016;37(4):606\u201312.","journal-title":"Subst Abus"},{"issue":"2","key":"4060_CR37","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.2196\/mhealth.3437","volume":"3","author":"A Genz","year":"2015","unstructured":"Genz A, Kirk G, Piggott D, Mehta SH, Linas BS, Westergaard RP. Uptake and acceptability of information and Communication Technology in a community-based cohort of people who inject drugs: implications for Mobile Health Interventions. JMIR Mhealth Uhealth. 2015;3(2):e70.","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"4060_CR38","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/08897077.2021.1975871","volume":"43","author":"JE Ozga","year":"2022","unstructured":"Ozga JE, Paquette C, Syvertsen JL, Pollini RA. Mobile phone and internet use among people who inject drugs: implications for mobile health interventions. Subst Abus. 2022;43(1):592\u20137.","journal-title":"Subst Abus"},{"issue":"3","key":"4060_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/09540121.2021.1894319","volume":"34","author":"AM Teitelman","year":"2022","unstructured":"Teitelman AM, Tieu H-V, Flores D, et al. Individual, social and structural factors influencing PrEP uptake among cisgender women: a theory-informed elicitation study. AIDS Care. 2022;34(3):273\u201383.","journal-title":"AIDS Care"},{"issue":"1","key":"4060_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12879-022-07572-3","volume":"22","author":"AR King","year":"2022","unstructured":"King AR, Shah S, Randall LA, et al. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings. BMC Infect Dis. 2022;22(1):737.","journal-title":"BMC Infect Dis"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-023-04060-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-023-04060-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T10:13:19Z","timestamp":1695377599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-023-04060-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4060"],"URL":"https:\/\/doi.org\/10.1007\/s10461-023-04060-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2023,4,10]]},"assertion":[{"value":"31 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study was approved by the Institutional Review Board of the University of Pennsylvania.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from all participants. No participants withdrew from the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}